サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1363100

医薬品安定および保管サービスの北米と欧州市場規模、シェア、動向分析レポート：サービス別、分子別、モード別、地域別、セグメント別予測、2023年～2030年

North America And Europe Pharmaceutical Stability & Storage Services Market Size, Share & Trends Analysis Report By Services (Stability, Storage), By Molecule (Large Molecule, Small Molecule), By Mode, By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 133 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
医薬品安定および保管サービスの北米と欧州市場規模、シェア、動向分析レポート：サービス別、分子別、モード別、地域別、セグメント別予測、2023年～2030年
出版日: 2023年09月20日
発行: Grand View Research
ページ情報: 英文 133 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米と欧州の医薬品安定および保管サービス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、北米と欧州の医薬品安定および保管サービス市場規模は2030年までに32億2,000万米ドルに達する見込みです。

同市場は2023年から2030年にかけてCAGR 5.5％で成長すると予測されています。厳しい規制要件、研究開発投資の増加、臨床試験の世界化は、市場成長を促進する主な要因の一部です。

バイオシミラーに対する需要の高まりは、市場の進展を促進すると予想されます。近年、バイオシミラーの承認率は著しく向上しています。2020年に発表されたAmgen Biosimilars Trend Reportによると、米国ではバイオシミラーの承認数が前年から65%増加し、2023年現在、米国では41品目、EUでは70品目以上が承認されています。バイオシミラーの承認拡大が市場にプラスの影響を与える可能性が高いです。

医薬品の安定性は、医薬品の強度と有効性を決定する上で重要な役割を果たします。しかし、安定性を確保するためには、規制機関によってデータ要件や試験規制が異なるという課題があり、多様な地域での製品販売が特に難しくなっています。EMAとFDAはともに安定性試験に関するICHガイドラインを遵守していますが、これらの試験にはそれぞれ異なる微生物学的限界値が設定されています。その結果、米国では任意である特定の評価がEUでは必須となり、その逆もあります。このような相違は安定性試験手順を複雑にし、このような試験サービスのアウトソーシングの必要性を高めています。

いくつかの企業は、市場での地位を獲得するために、買収、提携、新サービスの立ち上げなどの戦略に取り組んでいます。例えば、2023年3月、BioLife Solutions社は、ULT Freezersのバックアップ冷却を提供し、卓上生物学的製剤保存のドライアイス代替品として機能するUltraguard-70℃相変化材料（PCM）アクセサリーを発表しました。さらに、2022年10月、CSafeとBioLife Solutions, Inc.は、細胞・遺伝子治療のサプライチェーンソリューションを強化するためにパートナーシップを締結しました。CSafeは、細胞・遺伝子治療市場にコールドチェーン・ソリューションを提供するBioLife社の世界・パートナー・ネットワークに加わっています。

北米と欧州の医薬品安定および保管サービス市場レポートハイライト：

  • 2022年は安定性分野が地域市場を独占し、バイオ医薬品と個別化医薬品の需要の急増が、医薬品安定性サービスの進歩を促進しています。
  • サービス別では、発展途上地域におけるジェネリック医薬品やバイオシミラー医薬品への注目の高まりにより、保管分野が予測期間中に6.1%のCAGRを記録すると予測されます。
  • 2022年の市場は、低分子セグメントが支配的でした。予測、構造ベースの設計、イメージング、自動化、人工知能、機械学習における最近の進歩は、低分子のリード最適化のペースと成功率を高める重要な促進要因となっています。
  • 高分子セグメントも市場で大きなシェアを占めています。これは、タンパク質、核酸、炭水化物、生体細胞、組織などの高分子の採用が増加しているためです。
  • 2022年には、自社部門が最大の市場シェアを占めました。ほとんどの製薬メーカーは、自社での安定性試験を選択しています。これらの試験は、すべての医薬品、臨床試験のすべてのフェーズで実施することが義務付けられているからです。
  • 北米は市場を独占し、2022年には71.51%の最大売上シェアを占めました。これは、同地域で安定性試験と保管サービスを提供する大手市場プレーヤーが複数存在するためです。
  • 欧州も今後数年間は大きなシェアを占めると予想されます。英国は医薬品分野の研究開発に力を入れています。企業が新薬の開発や臨床試験の実施に投資する中、こうした活動をサポートする安定性試験・保管サービスへの需要が高まっています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 医薬品安定および保管サービスの市場変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 付随市場の見通し
  • 医薬品安定および保管サービス市場
  • 市場力学
    • 市場促進要因の影響分析
    • 市場抑制要因分析
    • 業界の動向
    • 機会分析
  • ポーターのファイブフォース分析
  • PESTEL分析
  • 新型コロナウイルス感染症（COVID-19）が北米および欧州の医薬品安定および保管サービス市場に与える影響

第4章 北米および欧州の医薬品安定および保管サービス市場：サービス別セグメント分析、2018年～2030年

  • 北米および欧州の医薬品安定および保管サービス市場：サービス変動分析
  • サービス別
  • 安定
  • 保管

第5章 北米および欧州の医薬品安定および保管サービス市場：分子別セグメント分析、2018年～2030年

  • 北米と欧州の分子別医薬品安定および保管サービス市場：重要なポイント
  • 分子の変動分析と市場シェア、2022年と2030年
  • 分子別
  • 低分子
  • 高分子

第6章 北米および欧州の医薬品安定および保管サービス市場：モード別セグメント分析、2018年から2030年

  • 北米と欧州のモード別医薬品安定および保管サービス市場：重要なポイント
  • モード変動分析と市場シェア、2022年と2030年
  • モード別
  • 社内
  • アウトソーシング

第7章 北米と欧州の医薬品安定および保管サービス市場：サービス別、分子別、モード別の地域推定・動向分析

  • 北米および欧州の医薬品安定および保管サービス市場：地域別の展望
  • 北米
  • 欧州

第8章 競合情勢

  • ヒートマップ分析
  • 参入企業の概説
  • 財務実績
  • サービスのベンチマーク
  • 戦略マッピング
    • 取得
    • 拡大
    • パートナーシップとコラボレーション
    • 製品の発売
  • 企業の市場シェア分析（2022）
  • 企業リスト
図表

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. North America and Europe Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 4. North America and Europe Pharmaceutical Stability & Storage Services Market by Molecule, 2018 - 2030 (USD Million)
  • Table 5. North America and Europe Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 6. North America and Europe Pharmaceutical Stability & Storage Services Market by Region, 2018 - 2030 (USD Million)
  • Table 7. North America Pharmaceutical Stability & Storage Services Market by Country, 2018 - 2030 (USD Million)
  • Table 8. North America Pharmaceutical Stability & Storage Services Market by Service, 2018 - 2030 (USD Million)
  • Table 9. North America Pharmaceutical Stability & Storage Services Market by Molecule, 2018-2030 (USD Million)
  • Table 10. North America Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 11. U.S. Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 12. U.S. Pharmaceutical Stability & Storage Services Market by Molecule, 2018 - 2030 (USD Million)
  • Table 13. U.S. Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 14. Canada Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 15. Canada Pharmaceutical Stability & Storage Services Market by Molecule, 2018 - 2030 (USD Million)
  • Table 16. Canada Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 17. Europe Pharmaceutical Stability & Storage Services Market by Country, 2018 - 2030 (USD Million)
  • Table 18. Europe Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 19. Europe Pharmaceutical Stability & Storage Services Market by Molecules, 2018 - 2030 (USD Million)
  • Table 20. Europe Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 21. Germany Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 22. Germany Pharmaceutical Stability & Storage Services Market by Molecules, 2018 - 2030 (USD Million)
  • Table 23. Germany Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 24. UK Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 25. UK Pharmaceutical Stability & Storage Services Market by Molecules, 2018 - 2030 (USD Million)
  • Table 26. UK Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 27. France Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 28. France Pharmaceutical Stability & Storage Services Market by Molecules, 2018 - 2030 (USD Million)
  • Table 29. France Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 30. Italy Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 31. Italy Pharmaceutical Stability & Storage Services Market by Molecules, 2018 - 2030 (USD Million)
  • Table 32. Italy Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 33. Spain Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 34. Spain Pharmaceutical Stability & Storage Services Market by Molecules, 2018 - 2030 (USD Million)
  • Table 35. Spain Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 36. Denmark Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 37. Denmark Pharmaceutical Stability & Storage Services Market by Molecules, 2018 - 2030 (USD Million)
  • Table 38. Denmark Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 39. Sweden Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 40. Sweden Pharmaceutical Stability & Storage Services Market by Molecules, 2018 - 2030 (USD Million)
  • Table 41. Sweden Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 42. Norway Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 43. Norway Pharmaceutical Stability & Storage Services Market by Molecules, 2018 - 2030 (USD Million)
  • Table 44. Norway Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Pharmaceutical Stability & Storage Services Market: Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 10 Penetration & Growth Prospect Mapping
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Market Penetration vs. Growth Prospect Mapping, 2021
  • Fig. 14 Regional Marketplace: Key Takeaways
  • Fig. 15 North America and Europe Pharmaceutical Stability & Storage Services Market for Stability, 2018 - 2030 (USD Million)
  • Fig. 16 North America and Europe Pharmaceutical Stability & Storage Services Market for Drug Substance, 2018 - 2030 (USD Million)
  • Fig. 17 North America and Europe Pharmaceutical Stability & Storage Services Market for Stability indicating method validation , 2018 - 2030 (USD Million)
  • Fig. 18 North America and Europe Pharmaceutical Stability & Storage Services Market for Accelerated stability testing , 2018 - 2030 (USD Million)
  • Fig. 19 North America and Europe Pharmaceutical Stability & Storage Services Market for Photostability Testing , 2018 - 2030 (USD Million)
  • Fig. 20 North America and Europe Pharmaceutical Stability & Storage Services Market for Other stability testing methods, 2018 - 2030 (USD Million)
  • Fig. 21 North America and Europe Pharmaceutical Stability & Storage Services Market for Storage, 2018 - 2030 (USD Million)
  • Fig. 22 North America and Europe Pharmaceutical Stability & Storage Services Market for Cold storage, 2018 - 2030 (USD Million)
  • Fig. 23 North America and Europe Pharmaceutical Stability & Storage Services Market for Non-cold storage, 2018 - 2030 (USD Million)
  • Fig. 24 North America and Europe Pharmaceutical Stability & Storage Services Market for Small Molecule, 2018 - 2030 (USD Million)
  • Fig. 25 North America and Europe Pharmaceutical Stability & Storage Services Market for Research Products, 2018 - 2030 (USD Million)
  • Fig. 26 North America and Europe Pharmaceutical Stability & Storage Services Market for Commercial Products, 2018 - 2030 (USD Million)
  • Fig. 27 North America and Europe Pharmaceutical Stability & Storage Services Market for Large Molecule, 2018 - 2030 (USD Million)
  • Fig. 28 North America and Europe Pharmaceutical Stability & Storage Services Market for Research Products, 2018 - 2030 (USD Million)
  • Fig. 29 North America and Europe Pharmaceutical Stability & Storage Services Market for Commercial Products, 2018 - 2030 (USD Million)
  • Fig. 30 North America and Europe Pharmaceutical Stability & Storage Services Market for In-house services, 2018 - 2030 (USD Million)
  • Fig. 31 North America and Europe Pharmaceutical Stability & Storage Services Market for Outsourcing services, 2018 - 2030 (USD Million)
  • Fig. 32 Regional Outlook, 2021 & 2030
  • Fig. 33 North America Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 35 Canada Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 37 Germany Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 38 UK Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 39 France Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 40 Italy Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 41 Spain Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 44 Norway Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-123-7

North America And Europe Pharmaceutical Stability & Storage Services Market Growth & Trends:

The North America and Europe pharmaceutical stability & storage services market size is expected to reach USD 3.22 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to grow at a CAGR of 5.5% from 2023 to 2030. Stringent regulatory requirements, increasing R&D investments, and globalization of clinical trials are some of the major factors driving market growth.

The rising demand for biosimilars is expected to drive market advancement. In recent years, the approval rate for biosimilars has significantly improved. As per the Amgen Biosimilars Trend Report published in 2020, there was an increase in the number of biosimilar approvals by 65% since the preceding year in the U.S. As of 2023, 41 biosimilars were approved in the U.S., and over 70 were approved in the EU. The growing approval of biosimilars is likely to positively impact the market.

The stability of pharmaceuticals plays a crucial role in determining the strength and effectiveness of the medication. However, ensuring stability poses challenges due to varying data requirements and testing regulations imposed by different regulatory bodies, making it particularly difficult to market products in diverse regions. While both the EMA and FDA adhere to the ICH guidelines for stability testing, they maintain distinct microbiological limits for these tests. Consequently, certain evaluations that are optional in the United States become mandatory in the European Union, and vice versa. These disparities complicate stability testing procedures, leading to an increased need for outsourcing such testing services.

Several companies are involved in strategies such as acquisitions, collaborations, and new service launches to gain positions in the market. For instance, in March 2023, BioLife Solutions introduced the Ultraguard -70°C Phase Change Material (PCM) Accessory to offer backup cooling in ULT Freezers and act as a dry ice substitute for benchtop biologic material storage. Moreover, in October 2022, CSafe and BioLife Solutions, Inc. formed a partnership to enhance supply chain solutions for cell and gene therapy. CSafe joined BioLife's global partner network of companies offering cold chain solutions for the cell and gene therapies market.

North America And Europe Pharmaceutical Stability & Storage Services Market Report Highlights:

  • The stability segment dominated the regional market in 2022. The rapid growth in the demand for biopharmaceuticals and personalized medicines is driving advancements in pharmaceutical stability services
  • Based on service, the storage segment is expected to witness the highest CAGR of 6.1% over the forecast period, owing to the increasing focus on generics and biosimilars in developing regions
  • The small molecules segment dominated the market in 2022. Recent advances in forecasting, structure-based design, imaging, automation, artificial intelligence, and machine learning have become critical facilitators for increasing small molecule lead optimization's pace and success rates
  • The large molecule segment also holds a significant share in the market. This is due to the increasing adoption of large molecules such as proteins, nucleic acids, carbohydrates, living cells, and tissues
  • In 2022, the in-house segment held the largest market share. Most pharmaceutical manufacturers choose in-house stability testing, as these tests are required to be performed for all drugs and in all phases of clinical studies
  • North America dominated the market, accounting for the largest revenue share of 71.51% in 2022, due to the presence of several major market players providing stability and storage services in the region
  • Europe is also expected to account for a significant share of the market in the coming years. The UK has a strong emphasis on R&D in the pharmaceutical sector. As companies invest in developing new drugs and conducting clinical trials, there is an increased demand for stability testing and storage services to support these activities

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
  • 1.2 Market Definitions
  • 1.3 Research Methodology
  • 1.4 Information Procurement
    • 1.4.1 Information analysis
    • 1.4.2 Market formulation & data visualization
    • 1.4.3 Data validation & publishing
  • 1.5 Research Scope and Assumptions
    • 1.5.1 Approach 1: Commodity Flow Analysis
    • 1.5.2 Approach 2: Hybrid Model Analysis
    • 1.5.3 Hybrid Model market estimation
    • 1.5.4 Region/Country-based segment share calculation
    • 1.5.5 Multivariate analysis
    • 1.5.6 CAGR Calculation
  • 1.6 List of Secondary Sources
  • 1.7 Objectives
    • 1.7.1 Objective - 1
    • 1.7.2 Objective - 2
    • 1.7.3 Objective - 3
    • 1.7.4 Objective - 4

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Segment Snapshot
  • 2.4 Competitive Landscape Snapshot

Chapter 3 Pharmaceutical Stability & Storage Services Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Pharmaceutical Stability & Storage Services Market
  • 3.3 Market Dynamics
    • 3.3.1 Market driver impact analysis
      • 3.3.1.1 High R&D spending of pharmaceutical & biotechnology companies
      • 3.3.1.2 Growing demand for outsourcing stability testing due to the high complexity associated with drug stability
      • 3.3.1.3 Growing demand for biosimilars
    • 3.3.2 Market restraint analysis
      • 3.3.2.1 Stringent regulations for Pharmaceutical Stability and Storage Services of drugs
      • 3.3.2.2 Issues Associated with stability chambers
    • 3.3.3 Industry Trends
      • 3.3.3.1 Expansion of cold chain logistics
    • 3.3.4 Opportunity Analysis
      • 3.3.4.1 Increasing demand for personalized medicine
  • 3.4 Porter's Five Forces Analysis
  • 3.5 PESTEL Analysis
  • 3.6 Impact of COVID-19 on North America and Europe Pharmaceutical Stability & Storage Services Market

Chapter 4 North America and Europe Pharmaceutical Stability & Storage Services Market: Segment Analysis, by Services, 2018 - 2030 (USD Million)

  • 4.1 North America and Europe Pharmaceutical Stability & Storage Services Market: Services Movement Analysis
  • 4.2 North America and Europe Pharmaceutical Stability & Storage Services Market Estimates & Forecast, By Services (USD Million)
    • 4.2.1 North America and Europe Pharmaceutical Stability & Storage Services Market Estimates & Forecast, By Stability Type (USD Million)
    • 4.2.2 North America and Europe Pharmaceutical Stability & Storage Services Market Estimates & Forecast, By Storage Type (USD Million)
  • 4.3 Stability
    • 4.3.1 Drug Substance
    • 4.3.2 Stability indicating method validation
    • 4.3.3 Accelerated stability testing
    • 4.3.4 Photostability Testing
    • 4.3.5 Other stability testing methods
  • 4.4 Storage
    • 4.4.1 Cold
    • 4.4.2 Non-cold

Chapter 5 North America and Europe Pharmaceutical Stability & Storage Services Market: Segment Analysis, by Molecule, 2018 - 2030 (USD Million)

  • 5.1 North America and Europe Pharmaceutical Stability & Storage Services Market by Molecule: Key Takeaways
  • 5.2 Molecule Movement Analysis & Market Share, 2022 & 2030
  • 5.3 North America and Europe Pharmaceutical Stability & Storage Services Market Estimates & Forecast, By Molecule (USD Million)
    • 5.3.1 North America and Europe Pharmaceutical Stability & Storage Services Market Estimates & Forecast, By Small Molecules (USD Million)
    • 5.3.2 North America and Europe Pharmaceutical Stability & Storage Services Market Estimates & Forecast, By Large Molecules (USD Million)
  • 5.4 Small Molecule
    • 5.4.1 Small Molecule market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2 Research Products
      • 5.4.2.1 Research Products market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3 Commercial Products
      • 5.4.3.1 Commercial Products market estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5 Large Molecule
    • 5.5.1 Large Molecule market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.2 Research Products
      • 5.5.2.1 Research Products market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3 Commercial Products
      • 5.5.3.1 Commercial Products market estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6 North America and Europe Pharmaceutical Stability & Storage Services Market: Segment Analysis, by Mode, 2018 - 2030 (USD Million)

  • 6.1 North America and Europe Pharmaceutical Stability & Storage Services Market by Mode: Key Takeaways
  • 6.2 Mode Movement Analysis & Market Share, 2022 & 2030
  • 6.3 North America and Europe Pharmaceutical Stability & Storage Services Market Estimates & Forecast, By Mode (USD Million)
  • 6.4 In-House
    • 6.4.1 In-House market estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5 Outsourcing
    • 6.5.1 Outsourcing market estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7 North America and Europe Pharmaceutical Stability & Storage Services Market: Regional Estimates and Trend Analysis, by Services, by Molecule, by Mode.

  • 7.1 North America and Europe Pharmaceutical Stability & Storage Services Market: Regional Outlook
  • 7.2 North America
      • 7.2.1.1 North America Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 Key Country Dynamics
      • 7.2.2.2 Competitive Scenario
      • 7.2.2.3 Regulatory Framework
      • 7.2.2.4 U.S. Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Key Country Dynamics
      • 7.2.3.2 Competitive Scenario
      • 7.2.3.3 Regulatory Framework
      • 7.2.3.2 Canada Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3 Europe
      • 7.3.1.1 Europe Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2 UK
      • 7.3.2.1 Key Country Dynamics
      • 7.3.2.2 Competitive Scenario
      • 7.3.2.3 Regulatory Framework
      • 7.3.2.4 UK Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3 Germany
      • 7.3.3.1 Key Country Dynamics
      • 7.3.3.2 Competitive Scenario
      • 7.3.3.3 Regulatory Framework
      • 7.3.3.4 Germany Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4 France
      • 7.3.4.1 Key Country Dynamics
      • 7.3.4.2 Competitive Scenario
      • 7.3.4.3 Regulatory Framework
      • 7.3.4.4 France Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5 Italy
      • 7.3.5.1 Key Country Dynamics
      • 7.3.5.2 Competitive Scenario
      • 7.3.5.3 Regulatory Framework
      • 7.3.5.4 Italy Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million
    • 7.3.6 Spain
      • 7.3.6.1 Key Country Dynamics
      • 7.3.6.2 Competitive Scenario
      • 7.3.6.3 Regulatory Framework
      • 7.3.6.4 Spain Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million
    • 7.3.7 Denmark
      • 7.3.7.1 Key Country Dynamics
      • 7.3.7.2 Competitive Scenario
      • 7.3.7.3 Regulatory Framework
      • 7.3.7.4 Denmark Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million
    • 7.3.8 Sweden
      • 7.3.8.1 Key Country Dynamics
      • 7.3.8.2 Competitive Scenario
      • 7.3.8.3 Regulatory Framework
      • 7.3.8.4 Sweden Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million
    • 7.3.9 Norway
      • 7.3.9.1 Key Country Dynamics
      • 7.3.9.2 Competitive Scenario
      • 7.3.9.3 Regulatory Framework
      • 7.3.9.4 Norway Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million

Chapter 8 Competitive Landscape

  • 8.1 Heat Map Analysis
  • 8.2 Participants Overview
  • 8.3 Financial Performance
  • 8.4 Service Benchmarking
  • 8.5 Strategy Mapping
    • 8.5.1 Acquisition
    • 8.5.2 Expansion
    • 8.5.3 Partnership & Collaboration
    • 8.5.4 Product Launch
  • 8.6 Company Market Share Analysis (2022)
  • 8.7 List of Players